Healthcare Sector Performance: IBB1.F's price heavily relies on the overall performance of the healthcare sector, driven by factors like drug approvals, clinical trial results, and regulatory changes.

Pharmaceutical Company Performance: As IBB1.F holds significant pharmaceutical companies, their individual stock performances, influenced by factors like earnings reports and new drug launches, directly impact the ETF's price.

Biotechnology Company Performance: Biotechnology firms constitute a substantial portion of IBB1.F. Breakthroughs in research, FDA approvals, and clinical data significantly affect their stock values and, consequently, IBB1.F's price.

Interest Rate Changes: Interest rate hikes can negatively impact healthcare stocks, making IBB1.F less attractive. Lower rates tend to have the opposite effect.

Economic Growth: A strong economy generally supports healthcare spending, boosting the sector. Conversely, economic downturns may lead to reduced healthcare investment, impacting IBB1.F.

Government Regulations: Government policies regarding healthcare, drug pricing, and insurance coverage have a significant influence on the healthcare sector and, therefore, IBB1.F.

Investor Sentiment: Overall investor sentiment towards the healthcare sector, influenced by market trends and news events, plays a crucial role in IBB1.F's price fluctuations.